See more : The Pebble Group plc (PEBB.L) Income Statement Analysis – Financial Results
Complete financial analysis of GRAIL, Inc. Common Stock (GRALV) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of GRAIL, Inc. Common Stock, a leading company in the Medical – Diagnostics & Research industry within the Healthcare sector.
- Terna – Rete Elettrica Nazionale Società per Azioni (TRN.MI) Income Statement Analysis – Financial Results
- Rishabh Instruments Limited (RISHABH.BO) Income Statement Analysis – Financial Results
- PT Steady Safe Tbk (SAFE.JK) Income Statement Analysis – Financial Results
- Neurocrine Biosciences, Inc. (NBIX) Income Statement Analysis – Financial Results
- Brinova Fastigheter AB (publ) (BRIN-B.ST) Income Statement Analysis – Financial Results
GRAIL, Inc. Common Stock (GRALV)
About GRAIL, Inc. Common Stock
GRAIL, LLC, a biotechnology company, focuses on developing technologies for early cancer detection. The company develops Galleri, a screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer. It is also developing minimal residual disease and other post-diagnostic tests. GRAIL, LLC was formerly known as PSC15, Inc. and changed its name to GRAIL, LLC in January 2016. The company was incorporated in 2015 and is based in Menlo Park, California. GRAIL, LLC operates as a subsidiary of Illumina, Inc.
Source: https://incomestatements.info
Category: Stock Reports